Sherbrooke Park Advisers »

Monte Rosa Therapeutics shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $106k 20k 5.30

More positions owned by Sherbrooke Park Advisers

Gap (GAP)
Smartsheet Com Cl A (SMAR)
Lennar Corp Cl A (LEN)
Pure Storage Cl A (PSTG)
Micron Technology (MU)
Campbell Soup Company (CPB)
Ida (IDA)
AeroVironment (AVAV)
Pagerduty (PD)
Devon Energy Corporation (DVN)
Korn Ferry Com New (KFY)
Cardinal Health (CAH)
ConAgra Foods (CAG)
Amazon (AMZN)
Cirrus Logic (CRUS)

View all positions for Sherbrooke Park Advisers

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
BlackRock
Aisling Capital Management
Alphabet
Citadel Advisors
Geode Capital Management
Vestal Point Capital
State Street Corporation
Parkwood
ExodusPoint Capital Management

View all funds holding Monte Rosa Therapeutics